A carregar...
Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
INTRODUCTION: Recent years have seen a dramatic escalation of off-label prescribing for gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being released over the past two decades, but also in part as a response to increasing calls for multimodal and non-opioid pain...
Na minha lista:
| Publicado no: | Pain Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7648827/ https://ncbi.nlm.nih.gov/pubmed/32737803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-020-00189-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|